Cargando…

Target Blood Pressure in Patients with Diabetes: Asian Perspective

Recently, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) blood pressure (BP) trial enrolled 4733 participants with type 2 diabetes and randomized them to a target systolic blood pressure (SBP) of less than 120 mm Hg or 140 mm Hg. Despite the significant difference in the achieved SBP...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sungha, Kario, Kazuomi, Park, Chang-Gyu, Huang, Qi-Fang, Cheng, Hao-min, Hoshide, Satoshi, Wang, Ji-Guang, Chen, Chen-Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011260/
https://www.ncbi.nlm.nih.gov/pubmed/27593856
http://dx.doi.org/10.3349/ymj.2016.57.6.1307
_version_ 1782451794378489856
author Park, Sungha
Kario, Kazuomi
Park, Chang-Gyu
Huang, Qi-Fang
Cheng, Hao-min
Hoshide, Satoshi
Wang, Ji-Guang
Chen, Chen-Huan
author_facet Park, Sungha
Kario, Kazuomi
Park, Chang-Gyu
Huang, Qi-Fang
Cheng, Hao-min
Hoshide, Satoshi
Wang, Ji-Guang
Chen, Chen-Huan
author_sort Park, Sungha
collection PubMed
description Recently, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) blood pressure (BP) trial enrolled 4733 participants with type 2 diabetes and randomized them to a target systolic blood pressure (SBP) of less than 120 mm Hg or 140 mm Hg. Despite the significant difference in the achieved SBP, there was no significant difference in the incidence of primary outcomes. Based on this evidence, the target SBP for diabetics has been revised in the majority of major guidelines. However, there is a steeper association between SBP and stroke in Asians than other ethnicities, with stroke being the leading cause of cardiovascular mortality. This suggests that target BP in the Asian region should be tailored towards prevention of stroke. In the ACCORD study, the intensive BP treatment was associated with significant reductions in both total stroke and non-fatal stroke. The results from the ACCORD study are supported by a subgroup analysis from the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) study, which showed that, in diabetic patients, the risk of stroke continues to decrease to a SBP value of 115 mm Hg with no evidence of J curve. As diabetes is highly associated with underlying coronary artery disease, there is a justified concern for adverse effects resulting from too much lowering of BP. In a post hoc analysis of 6400 diabetic subjects enrolled in the International Verapamil SR-Trandolapril (INVEST) study, subjects with SBP of less than 110 mm Hg were associated with a significant increase in all-cause mortality. In the ONTARGET study, at any levels of achieved SBP, diastolic blood pressure (DBP) below 67 mm Hg was associated with increased risk for cardiovascular outcomes. As such, a prudent approach would be to target a SBP of 130–140 mm Hg and DBP of above 60 mm Hg in diabetics with coronary artery disease. In conclusion, hypertension, in association with diabetes, has been found to be significantly correlated with an elevated risk for cardiovascular events. As the association between stroke and BP is stronger in Asians, compared to other ethnicities, consideration should be given for a target BP of 130/80 mm Hg in Asians.
format Online
Article
Text
id pubmed-5011260
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-50112602016-11-01 Target Blood Pressure in Patients with Diabetes: Asian Perspective Park, Sungha Kario, Kazuomi Park, Chang-Gyu Huang, Qi-Fang Cheng, Hao-min Hoshide, Satoshi Wang, Ji-Guang Chen, Chen-Huan Yonsei Med J Review Article Recently, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) blood pressure (BP) trial enrolled 4733 participants with type 2 diabetes and randomized them to a target systolic blood pressure (SBP) of less than 120 mm Hg or 140 mm Hg. Despite the significant difference in the achieved SBP, there was no significant difference in the incidence of primary outcomes. Based on this evidence, the target SBP for diabetics has been revised in the majority of major guidelines. However, there is a steeper association between SBP and stroke in Asians than other ethnicities, with stroke being the leading cause of cardiovascular mortality. This suggests that target BP in the Asian region should be tailored towards prevention of stroke. In the ACCORD study, the intensive BP treatment was associated with significant reductions in both total stroke and non-fatal stroke. The results from the ACCORD study are supported by a subgroup analysis from the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) study, which showed that, in diabetic patients, the risk of stroke continues to decrease to a SBP value of 115 mm Hg with no evidence of J curve. As diabetes is highly associated with underlying coronary artery disease, there is a justified concern for adverse effects resulting from too much lowering of BP. In a post hoc analysis of 6400 diabetic subjects enrolled in the International Verapamil SR-Trandolapril (INVEST) study, subjects with SBP of less than 110 mm Hg were associated with a significant increase in all-cause mortality. In the ONTARGET study, at any levels of achieved SBP, diastolic blood pressure (DBP) below 67 mm Hg was associated with increased risk for cardiovascular outcomes. As such, a prudent approach would be to target a SBP of 130–140 mm Hg and DBP of above 60 mm Hg in diabetics with coronary artery disease. In conclusion, hypertension, in association with diabetes, has been found to be significantly correlated with an elevated risk for cardiovascular events. As the association between stroke and BP is stronger in Asians, compared to other ethnicities, consideration should be given for a target BP of 130/80 mm Hg in Asians. Yonsei University College of Medicine 2016-11-01 2016-08-30 /pmc/articles/PMC5011260/ /pubmed/27593856 http://dx.doi.org/10.3349/ymj.2016.57.6.1307 Text en © Copyright: Yonsei University College of Medicine 2016 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Park, Sungha
Kario, Kazuomi
Park, Chang-Gyu
Huang, Qi-Fang
Cheng, Hao-min
Hoshide, Satoshi
Wang, Ji-Guang
Chen, Chen-Huan
Target Blood Pressure in Patients with Diabetes: Asian Perspective
title Target Blood Pressure in Patients with Diabetes: Asian Perspective
title_full Target Blood Pressure in Patients with Diabetes: Asian Perspective
title_fullStr Target Blood Pressure in Patients with Diabetes: Asian Perspective
title_full_unstemmed Target Blood Pressure in Patients with Diabetes: Asian Perspective
title_short Target Blood Pressure in Patients with Diabetes: Asian Perspective
title_sort target blood pressure in patients with diabetes: asian perspective
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011260/
https://www.ncbi.nlm.nih.gov/pubmed/27593856
http://dx.doi.org/10.3349/ymj.2016.57.6.1307
work_keys_str_mv AT parksungha targetbloodpressureinpatientswithdiabetesasianperspective
AT kariokazuomi targetbloodpressureinpatientswithdiabetesasianperspective
AT parkchanggyu targetbloodpressureinpatientswithdiabetesasianperspective
AT huangqifang targetbloodpressureinpatientswithdiabetesasianperspective
AT chenghaomin targetbloodpressureinpatientswithdiabetesasianperspective
AT hoshidesatoshi targetbloodpressureinpatientswithdiabetesasianperspective
AT wangjiguang targetbloodpressureinpatientswithdiabetesasianperspective
AT chenchenhuan targetbloodpressureinpatientswithdiabetesasianperspective
AT targetbloodpressureinpatientswithdiabetesasianperspective